Class REMS For Botulinum Toxin Products Warns Against Interchangeabilty
FDA announced a class-wide REMS for botulinum toxin products that focuses on the dangers on interchangeability of the drugs.
FDA announced a class-wide REMS for botulinum toxin products that focuses on the dangers on interchangeability of the drugs.